Signaturefd, LLC Coherus Bio Sciences, Inc. Transaction History

Signaturefd, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	BUY	$3.79 - $8.3 $144 - $315	38 Added 36.19%	143 $0
Q4 2022 Jan 27, 2023	SELL	$5.69 - $10.07 $301 - $533	-53 Reduced 33.54%	105 $0
Q3 2022 Nov 08, 2022	BUY	$7.17 - $13.87 $157 - $305	22 Added 16.18%	158 $2,000
Q2 2022 Aug 10, 2022	BUY	$5.86 - $13.23 $322 - $727	55 Added 67.9%	136 $1,000
Q1 2022 May 02, 2022	BUY	$10.92 - $16.41 $884 - $1,329	81 New	81 $1,000
Q4 2021 Jan 25, 2022	SELL	$15.81 - $18.99 $711 - $854	-45 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$12.68 - $17.79 $570 - $800	45 New	45 $1,000
Q2 2021 Jul 26, 2021	SELL	$12.95 - $15.41 $1,036 - $1,232	-80 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$14.42 - $21.39 $1,153 - $1,711	80 New	80 $1,000
Q4 2018 Feb 13, 2019	SELL	$8.65 - $16.28 $43 - $81	-5 Closed	0 $0
Q1 2018 May 08, 2018	BUY	$9.1 - $13.7 $45 - $68	5 New	5 $0

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $115M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.